34results about How to "Reduce the number of treatments" patented technology

The invention relates to the technical field of pulse ablation, in particular to an electrical pulse ablation apparatus for an endoscope. The electrical pulse ablation apparatus comprises an electrodeassembly, a pulse waveform generator, an electrode driving device, parameter input equipment and a control device, wherein the electrode assembly comprises a central pole and a tube pole, and is configured for passing through a working channel of the endoscope into the body and transmitting pulses to the tissue during use; the pulse waveform generator is coupled to the electrode assembly and usedfor transmitting pulse voltage to the electrode assembly; the electrode driving device is used for driving the central pole and the tube pole; the parameter input equipment is used for configuring coordinate information of an ablation area; the control device is in signal connection with the parameter input equipment and in control connection with the electrode driving device, and the control device controls the displacement of the central pole and tube pole according the preset coordinate information through the electrode driving device separately; when a discharging end of the electrode assembly reaches a preset position, the control device controls the connection of the pulse waveform generator and electrode assembly; a human body natural channel is used for conveying an electrode to acomplicated area of the human body for ablation, thereby reducing traumas to the human body.

The invention discloses an automatically-sealed thrombus-prevented venous indwelling needle and a use method thereof. The automatically-sealed thrombus-prevented venous indwelling needle comprises a needle base, a catheter and a puncture needle core, wherein the catheter is arranged at the front end of the needle base, and the puncture needle core axially penetrates through the needle base and the catheter; the internal cavity of the needle base is separated into a positive-pressure chamber and a transfusion chamber by a separation portion, the transfusion chamber is communicated with the catheter, and the separation portion is made from a medical sealing material; and the separation portion is provided with a seepage passage, so that liquid in the positive-pressure chamber can automatically and slowly flow into the transfusion chamber through the seepage passage when the positive-pressure chamber and the transfusion chamber have pressure difference. The automatically-sealed thrombus-prevented venous indwelling needle and the use method of the automatically-sealed thrombus-prevented venous indwelling needle have the beneficial technical effects that the catheter is sealed automatically when transfusion is suspended according to conventional operations, and the liquid in the positive-pressure chamber slowly flows into the transfusion chamber through the seepage passage; and the seepage speed is slowed down along with the reducing of the pressure difference between the positive-pressure chamber and the transfusion chamber, so that the positive-pressure chamber can maintain positive pressure for a long time.

The invention relates to valnemulin hydrochloride microspheres and preparation method thereof. The valnemulin hydrochloride microspheres are composed of a water phase, an oil phase and a crosslinking agent, wherein a volume ration of the water phase to the oil phase is 1:6-12. The water phase is composed of gelatin, valnemulin hydrochloride, polyvinylpyrrolidone and purified water and the oil phase is composed of an emulsifier and liquid paraffin. The preparation method includes following steps: preparing the water phase and the oil phase, adding the water phase dropwisely to the oil phase, adding the crosslinking agent, washing off the liquid paraffin on surfaces of the microspheres through petroleum ether and performing a vacuum-drying process to obtain the valnemulin hydrochloride microspheres.

A Chinese medicine in the form of suppository for treating lumbar vertebra disease, lumbar intervertebral disc protrusion, tonic rachitis and hyperosteogeny is prepared from 9 Chinese-medicinal materials including astragalus root, capejasmine fruit, musk, cinnamon twig, etc through pulverizing, extracting in alcohol, filtering, concentrating by distilling, to obtain concentrated liquid, immersing catgut suture in physiologic saline, baking, shearing short, putting them in bottle, filling said concentrated liquid, sealing and magnetizing.

The present invention relates to an enhanced bedsore prevention member having a laminate structure composed of: a pad layer (10) of a synthetic resin material film, the pad layer (10) being produced in a sheet type by using synthetic resin material foam, hydrocolloid, or hydrogel coming into contact with skin; a cover layer (20) made of a synthetic resin material film material and integrally laminated on the outer surface of the pad layer (10); and an adhesive layer (30) provided on the inner surface of the cover layer (20) and having an adhesive applied thereonto, wherein the bedsore prevention member comprises: an opening (50) formed through the center thereof to allow an affected part of a patient's skin to be observed with the naked eye; a cover (40) openable / closable by being fitted and coupled corresponding to the shape of the opening (50); and a covering cover (90) provided on the upper outer surface of the cover (40) while having an area wider than the area of the cover.

The invention discloses a frame and a virus encoding bispecific molecules that secrete and mediate effector cells killing target cells. The recombinant protein provided by the present invention includes functional domain A and functional domain B; said functional domain A specifically binds to tumor-associated antigens or HLA polypeptide complexes on tumor cells; said functional domain B specifically binds to T cell surface markers or NK Cell surface markers. After the recombinant adenovirus provided by the present invention infects tumor cells, the tumor cells become factories for the expression of bispecific recombinant proteins, which can reduce the number of treatments compared with direct administration of fusion proteins. Introduce adenovirus into tumors by in situ injection , the expressed fusion protein can immediately bind to tumor cells without undergoing in vivo metabolism. Compared with direct injection of fusion protein, it is more efficient, and once there are effector cells around the tumor, it can be killed immediately. The invention has great value for tumor therapy.

A measuring system for estimating skin tissue microvascular depth comprises a biological tissue sample information collection module, a light source module, a speckle imaging module, a precise reflection signal measuring module, a radiation reverse method analysis module and an evaluation and correction module. On the basis of these six modules, skin tissue sample information is collected to acquire a skin tissue model and tissue optical parameters; blood and vessel two-dimensional profile information of a focus microvessel is acquired through a speckle system, and the vascular diameter is acquired through image recognition; a high-accuracy reflection signal of a tissue sample is acquired through reflective signal measuring; the above three kinds of information is taken as input parametersto enter the radiation reverse method analysis module to acquire an estimated value of depth of the focus microvessel, and distribution laws of laser energy in skin tissue is evaluated; recommendation laser thermal therapy parameters are acquired by combining with blood information, and theoretical guidance is provided for improving clinical treatment effect on vascular dermatosis like port-winestain.

A plasma display panel (PDP) and a method of manufacturing the same are provided. The PDP comprises a front panel (101) in which bus electrodes (102b,103b) comprising a black material (104) are formed on transparent electrodes (102a,103a) and a rear panel (111) attached to the front panel (101) to be separated from each other by a predetermined distance.

The invention relates to a medicinal composition for treating nevus flammeus and a preparation method thereof, wherein extraction and purification of hypericin are completed by the steps of (a) carrying out crude extraction, (b) refining by macroporous resin and (c) carrying out separation and purification; and the obtained hypericin is mixed with a medicinal carrier in a certain proportion to prepare the medicinal composition. The medicinal composition of the invention has the characteristics of effect on both mild and severe pathological changes, higher curative effect, lower dark toxicity and toxic and side effects, high safety degree, stronger synergistic effect with photodynamic affection, and capacity of addressing both the symptoms and root causes of nevus flammeus without carryingout the allergic test.

The invention discloses an antitumor combined medicine. The combined medicine comprises a diphosphonate compound serving as an active ingredient and CIK cells, wherein the diphosphonate compound is at least one of clinical medication etidronate disodium, clodronate disodium, pamidronate disodium, tiludronate disodium, alendronate sodium, neridronate sodium, olpadronate sodium, risedronate sodium, sodium ibandronate, incadronate disodium and zoledronic acid. The method for greatly improving the tumor cell killing capability of CIK cells by utilizing combination of anti-tumor-osseous-metastasis diphosphonate medicines and the CIK cells, so that the number of CIK cells for achieving the treatment effect the same as a conventional method is greatly reduced; and compared with biological treatment of single CIK cells, the combined medicine has the advantages that the relatively high safety of CIK cells can be maintained, and the treatment effect can be remarkably improved.

The invention relates to a pharmaceutical composition for treating skin diseases of pets. Each 100g of the pharmaceutical solution contains: 0.5-3g of fluconazole, 25-35g of C18 trans fatty acid, 0.5-3g of baicalein, and 0.5-3g of clove extract , tea tree oil 0.5‑3ml, hemp 0.5‑2g, glycerin 4‑6g, carbomer 0.2‑3g, triethanolamine 1‑2g, and the balance is distilled water. The pharmaceutical composition prepared by the invention has good drug efficacy, reduces the time for treating pet skin diseases, and has low recurrence rate.